DRG International Introduces The Totally Newly Designed
DRG:HYBRiD-XL® Analyzer
DRG HYBRiD-XL® - Fully automated Random Access Analyzer for Immunoassays and Clinical Chemistry
This innovative and unique technology allows, for the first time, the simultaneous measurement of immunoassays and clinical chemistry parameters including turbidimetric tests in one sample. The comprehensive assay menu will include routine and niche parameters.
Watch our Slide-Show introducingthe DRG: HYBRiD-XL®
|
|
Specifications |
Calibration:
|
|
Test Principle:
Samples/Cartridges:
|
Efficiency:
Handling/Interface:
|
![]() |
The DRG: HYBRiD-XL® unique, fully automated, random access analyzer will be available for order in 2011 |
|
|
This innovative and unique technology allows, for the first time, the simultaneous measurement of immunoassays and clinical chemistry parameters, including turbidimetric tests in one sample |
|
|
The lab top analyzer, ideal for medium-sized and small laboratories, provides diagnostic services to hospitals, clinics and large medical practice facilities |
|
|
Up to 40 tests of different types or 40 times of the same test, or up to 20-patient samples can be ordered by the medical practitioner over a wide range of pre-packaged tests to serve different specialties |
Fully automated Random Access Analyzer for Immunoassays and Clinical Chemistry
Targeted assay menu
| Anemia: | Diabetes: | Nephrology: |
|
|
|
| Tumormarker: |
Bone Metabolism: |
Inflammation: |
|
|
|
| Thyroid Function: |
TDM: |
Infectious Diseases: |
|
|
|
| Fertility: |
Cardiac Marker: |
|
|
|
|
| Prenatal Supervision: | Hypertension: | |
|
|
* not available in USA |






